These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 93404)

  • 1. Responses of patients to arabinosyladenine-5'-phosphate correlated with an in vitro test.
    Lepage GA; Khaliq A
    Adv Enzyme Regul; 1978; 17():437-54. PubMed ID: 93404
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
    Von Hoff DD; Kronmal R; O'Toole RV; Surwit EA; Hutton JJ; Alberts DS
    Am J Clin Oncol; 1988 Apr; 11(2):146-8. PubMed ID: 2451882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fludarabine phosphate in patients with recurrent glioma.
    Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
    Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
    Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
    Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
    Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
    Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
    J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group Study.
    Rainey JM; Hill JB; Crowley J
    Invest New Drugs; 1988 Apr; 6(1):45-6. PubMed ID: 2457565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Carpenter JT; Vogel CL; Wang G; Raney M
    Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Beltran G; Saiers JH; Oishi N; Von Hoff DD
    Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Von Hoff DD; Katterhagen JG; Coltman CA
    Cancer Treat Rep; 1987 Dec; 71(12):1319-20. PubMed ID: 2446754
    [No Abstract]   [Full Text] [Related]  

  • 13. Arabinosyladenine monophosphate in genital herpes: a double-blind, placebo-controlled study.
    Hatcher VA; Friedman-Kien AE; Marcus EL; Klein RJ
    Antiviral Res; 1982 Oct; 2(5):283-90. PubMed ID: 6185089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 2'-deoxycoformycin on the biologic half-life of 9-beta-D-arabinofuranosyladenine 5'-triphosphate in CHO cells.
    Shewach DS; Plunkett W
    Biochem Pharmacol; 1979 Aug; 28(15):2401-4. PubMed ID: 91375
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
    Kraut EH; Crowley JJ; Grever MR; Keppen MD; Bonnet JD; Hynes HE; Salmon SE
    Invest New Drugs; 1990 May; 8(2):199-200. PubMed ID: 1696569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virostatic therapy with adenine arabinoside].
    Werner TG
    Med Klin; 1978 Oct; 73(43):2. PubMed ID: 82198
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
    Weiss GB; Metch B; Von Hoff DD; Taylor SA; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1313-4. PubMed ID: 2446753
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
    J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
    Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
    J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
    Esteban R; Buti M; Vallés M; Allende H; Guardia J
    Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.